PAK2 and diffuse large B-cell lymphoma: We developed a novel prognostic MitoRGs signature for the survival of DLBCL patients and conducted preliminary research on the role of PAK2 gene, providing new insights into the prognosis of DLBCL patients and the mechanism of MitoRGs.